These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 4156665
1. Piperacetazine in ambulatory chronic schizophrenic patients. Rada RT, Donlon PT. Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665 [No Abstract] [Full Text] [Related]
2. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity. Donlon PT, Rada RT. Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106 [Abstract] [Full Text] [Related]
7. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients. Ban TA, Ananth JV, Lehmann HE. Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144 [No Abstract] [Full Text] [Related]
8. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients. Gallant DM, Bishop MP. Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346 [No Abstract] [Full Text] [Related]
9. Evaluation of piperacetazine (Quide) injection in acute schizophrenics. Kiev A, Güclü B, Kulkarni AS. Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517 [No Abstract] [Full Text] [Related]
10. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow. Hollister LE. Adv Biochem Psychopharmacol; 1974 Jul; 9(0):667-73. PubMed ID: 4151921 [No Abstract] [Full Text] [Related]
11. The effect of rubidium in schizophrenia. Chouinard G, Annable L. Commun Psychopharmacol; 1977 Jul; 1(4):373-83. PubMed ID: 28202 [No Abstract] [Full Text] [Related]
12. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study. Kulkarni AS. Adv Biochem Psychopharmacol; 1974 Jul; 9(0):691-9. PubMed ID: 4151770 [No Abstract] [Full Text] [Related]
13. Piperacetazine in the treatment of mixed neurotics. Lapierre YD, Lee M. Curr Ther Res Clin Exp; 1976 Jan; 19(1):105-9. PubMed ID: 1209 [No Abstract] [Full Text] [Related]
14. Piperacetazine study in state hospital patients. del Portillo L. J Med Assoc Ga; 1974 Dec; 63(12):465-7. PubMed ID: 4154960 [No Abstract] [Full Text] [Related]
15. Specific indications for different classes of phenothiazines. Hollister LE, Overall JE, Kimbell I, Pokorny A. Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660 [No Abstract] [Full Text] [Related]
16. Potential value of penfluridol and pipothiazine palmitate. Gallant DM. Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769 [No Abstract] [Full Text] [Related]
17. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. Salvesen C, Vaksdal K. PDM; 1974 Jan; 5-6(9-12;1-8):10-4. PubMed ID: 4156935 [No Abstract] [Full Text] [Related]
18. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial. Zwanikken GJ. Psychiatr Neurol Neurochir; 1973 Jan; 76(2):83-92. PubMed ID: 4573494 [No Abstract] [Full Text] [Related]
19. A clinical study with propericiazine in chronic psychotic patients. Deutsch M, Ananth JV, Ban TA. Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391 [No Abstract] [Full Text] [Related]